Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Precision Medicine in Oncology^®

Breast Cancer

Gastrointestinal Cancer

Precision Medicine in Oncology^®

New Technology Eases Information Overload in Precision Medicine

R. Steven Paulson, MD, discusses how to adapt to the era of precision medicine, the latest with liquid biopsies, and a unique diagnostic tool with the potential to revolutionize oncology.
Read More >>

Liquid Biopsies Are Shaping Future of Molecular Testing

Studies Add to Evidence of Utility of Blood-Based Biomarkers in NSCLC

Oncology Experts Preview Exciting Precision Medicine Research

Larotrectinib Elicits Clinically Meaningful PFS Improvement Through GMI in TRK Fusion+ Cancers

Technology Advances Aid Treatment Decisions for Community Oncologists

View More Stories >>

View Conference Coverage

2019 Lynn Sage Breast Cancer Symposium

2019 ESMO Congress

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

2019 World Conference on Lung Cancer

Dr. Papadimitrakopoulou on Implications of the NILE Trial in NSCLC

Dr. Papadimitrakopoulou on Benefits of Liquid Biopsy Versus Standard Tissue in Lung Cancer

Dr. Papadimitrakopoulou on Distinguishing Features of the Guardant360 Assay in Lung Cancer

Dr. Papadimitrakopoulou on the Utility of Liquid Biopsies in NSCLC

Dr. Chavez Mac Gregor on Chemotherapy in Node-Positive HR+/HER2- Breast Cancer

Dr. Strickler on Genomic Variants Detected by Liquid Biopsies in GI Cancers

OncLive houses thousands of videos that provide updates and information.
See more Videos

Treatment of NSCLC With RET Fusions

The NTRK Family of Fusions in NSCLC

Treatment of NSCLC Rare Genotypes

Treatment of Germline BRCA with PARP and Checkpoint

Managing CNS Disease in ALK-Rearranged NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

TRK Inhibition in CNS Tumors or Metastases

Considering Available Data for Entrectinib

TRK Inhibition: Personal Experience With Larotrectinib

Larotrectinib for NTRK Fusions: Patient Selection

Larotrectinib: The First FDA-Approved TRK Inhibitor

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Program

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.

Melanoma Updates

Pembrolizumab/Ipilimumab Shows Promising Efficacy
James Allison Predicts ‘Cures’ With Checkpoint Inhibitor Combinations
Nivolumab Survival Benefit Sustained in Updated Data
Novel T-VEC Combos Mark Next Phase of Oncolytic Immunotherapy Era
Novel Treatments, Targets Next Step in Immuno-Oncology Revolution

Download the meeting reporter >>>

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval in Myeloma, Label Update in HER2+ Breast Cancer, Breakthrough Status in Prostate Cancer, and More